Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Complications
Gangrenous foot development in diabetes mellitus may involve lipoprotein (a) levels
April 10th, 2006
Serum lipoprotein (a) levels may have a pathogenetic role in the development of gangrenous foot lesions in patients with diabetes mellitus. According to a study from Turkey, "Our aim was to see the levels of lipoprotein (a) (Lp (a)) in patients with gangrenous or non-gangrenous diabetic foot lesions. Twenty-two patients with gangrenous foot lesions, 11 with non-gangrenous foot lesions and 10 healthy subjects were included in the study." "All the patients had similar glycemic control and duration of diabetes. The main outcome measure was serum Lp (a) levels in both group of patients with diabetes and healthy subjects. Diabetic patients with gangrenous...
Source: Diabetes Week (2006-04-10)
|
